FindTrial
Sign In

To decrease the pain caused by the injection of propofol during general anaesthesia inchildren.

Effect of ramosetron on attenuation of propofol induced pain in pediatric patients - A randomized clinical comparative study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021601
Enrollment
120
Registered
2019-10-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Ramosetron: Ramosetron 6microgram/kg will be given intravenously prior to induction with propofol injection. Control Intervention1: Lidocaine: Lidocaine 0.2mg /kg will be given intrave

Sponsors

ESIC medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pediatric population of age group between 4-14 years belonging to American society of anaesthesiologist (ASA) class 1-2, undergoing General anaesthesia.

Exclusion criteria

Exclusion criteria: ASA 3-4, congenital heart diseases, associated co-morbidities

Design outcomes

Primary

MeasureTime frame
Pain scores during induction by using 4 point scale.Timepoint: Hemodynamic stability—

Secondary

MeasureTime frame
Hemodynamic changesTimepoint: First 30 minutes—

Countries

India

Contacts

Public ContactG B Sumalatha

ESIC medical college, Gulbarga

gbsumaravi@gmail.com09538301444

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026